Abstract
[6,7-3H] Estrone (E) and [6,7-3H]estradiol-17β (E2) have been synthesized by reduction of 6-dehydroestrone and 6-dehydroestradiol with tritium gas. Tritiated E and E2 were administered by oral gavage to female rats and to male and female hamsters on a dose level of about 300 μg/kg (54 mCi/kg). After 8 h, the liver was excised from the rats; liver and kidneys were taken from the hamsters. DNA was purified either directly from an organ homogenate or via chromatin. The radioactivity in the DNA was expressed in the units of the Covalent Binding Index, CBI = (μmol chemical bound per mol DNA-P)/(mmol chemical administered per kg b.w.). Rat liver DNA isolated via chromatin exhibited the very low values of 0.08 and 0.09 for E and E2, respectively. The respective figures in hamster liver were 0.08 and 0.11 in females and 0.21 and 0.18 in the males. DNA isolated from the kidney revealed a detectable radioactivity only in the female, with values of 0.03 and 0.05 for E and E2, respectively. The values for male hamster kidney were < 0.01 for both hormones. The minute radioactivity detectable in the DNA samples does not represent covalent binding to DNA, however, as indicated by two sets of control experiments. (A) Analysis by HPLC of the nucleosides prepared by enzyme digest of liver DNA isolated directly or via chromatin did not reveal any consistent peak which could have been attributed to a nucleoside-steroid adduct. (B) All DNA radioactivity could be due to protein contaminations, because the specific activity of chromatin protein was determined to be more than 3,000 times higher than of DNA. The high affinity of the hormone to protein was also demonstrated by in vitro incubations, where it could be shown that the specific activity of DNA and protein was essentially proportional to the concentration of radiolabelled hormone in the organ homogenate, regardless of whether the animal was treated or whether the hormone was added in vitro to the homogenate.
Carcinogens acting by covalent DNA binding can be classified according to potency on the basis of the Covalent Binding Index. Values of 103–104 have been found for potent, 102 for moderate, and 1–10 for weak carcinogens. Since estrone is moderately carcinogenic for the kidney of the male hamster, a CBI of about 100 would be expected. The actually measured limit of detection of 0.01 places covalent DNA binding among the highly unlikely mechanisms of action. Similar considerations can be made for the liver where any true covalent DNA binding must be below a level of 0.01. It is concluded that an observable tumor induction by estrone or estradiol is unlikely to be due to DNA binding.
Similar content being viewed by others
References
Baskevitch PP, Vignon F, Bousquet C, Rochefort H (1983) Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer. Cancer Res 43: 2290–2297
Blackburn MG, Orgee L, Williams GM (1977) Oxidative bonding of natural oestrogens to DNA by chemical and metabolic means. J Chem Soc Chem Commun 11: 386–387
Bolt HM, Kappus H (1974) Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase. J Steroid Biochem 5: 179–184
Brotherton J (1976) Sex hormone pharmacology. Academic Press, London, pp 479–481
Bucala R, Fishman J, Cerami A (1982) Formation of covalent adducts between cortisol and 16-hydroxyestrone and protein: Possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus. Proc Natl Acad Sci USA 79: 3320–3324
Cameron RG, Imaida K, Tsuda H, Ito N (1982) Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res 42: 2426–2428
Cerutti P (1978) Repairable damge in DNA. In: Hanawalt P, Friedberg E, Fox C (eds) DNA repair mechanism. Academic Press, New York, pp 1–14
Drevon C, Piccoli C, Montesano R (1981) Mutagenicity assays of estrogenic hormones in mammalian cells. Mutat Res 89: 83–90
Duncan SJ, Brookes P (1979) Lack of oestradiol-DNA binding in mouse embryo cell cultures or following rat-liver microsomal metabolism. Cancer Lett 6: 351–355
Henderson BE, Ross RK, Pike MC, Casagrande JT (1982) Endogenous hormones as a major factor in human cancer. Cancer Res 42: 3232–3239
Jaggi W, Lutz WK, Schlatter C (1978) Covalent binding of ethinylestradiol and estrone to rat liver DNA in vivo. Chem Biol Interact 23: 13–18
IARC (1974) Monographs on the evaluation of carcinogenic risk of chemicals to man, sex hormones, vol 6. International Agency for Research on Cancer, Lyon
IARC (1979) Monographs on the evaluation of the carcinogenic risk of chemicals to humans, sex hormones, vol 21. International Agency for Research on Cancer, Lyon
Kaiser H (1965) Zum Problem der Nachweisgrenze. Z Anal Chem 209: 1–19
Kappus H, Bolt HM, Remmer H (1973) Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro. Steroids 22: 203–225
Kappus H, Bolt HM (1976) Irreversible protein binding of norethisterone (norethindrone) epoxide. Steroids 27: 29–45
Lang R, Redmann U (1979) Non-mutagenicity of some sex hormones in the Ames Salmonella/microsome mutagenicity test. Mutat Res 67: 361–365
Lutz WK (1979) In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat Res 65: 289–356
Lutz WK (1982) Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens. In: Snyder R, Parke DV, Kocsis J, Jollow DJ, Gibson GG (eds) Biological reactive intermediates, chemical mechanism and biological effects. Plenum Press, New York, pp 1349–1365
Lutz WK, Jaggi W, Schlatter C (1982) Covalent binding of diethyl-stilbestrol to DNA in rat and hamster liver and kidney. Chem Biol Interact 42: 251–257
Maggs JL, Grabowski PS, Rose ME, Park BK (1982) The biotransformation of 17α-ethynyl[3H]estradiol in the rat- irreversible binding and biliary metabolites. Xenobiotica 12: 657–668
Marks F, Hecker E (1969) Metabolism and mechanism of action of oestrogens. XII. Structure and mechanism of formation of water-soluble and protein-bound metabolites of oestrone in rat-liver microsomes in vitro and in vivo. Biochim Biophys Acta 187: 250–265
Merrill EJ, Vernice GG (1970) Synthesis of [6,7-3H]-17-ethinylestradiol and [6,7-3H]-17-ethinylestradiol-cyclopentyl-1-14C-ether. J Labelled Compds 6: 266–275
Mitchell JR, Hughes H, Lauterburg BH, Smith CV (1982) Chemical nature of reactive intermediates as determinant of toxicologic responses. Drug Metab Rev 13: 539–553
Moore HW (1977) Bioactivation as a model design for bioreductive alkylation. Science 197: 527–532
Pelkonen O, Boobis AR, Nebert DW (1978) Genetic differences in the binding of reactive carcinogenic metabolites to DNA. Carcinogenesis 3: 383–400
Sagelsdorff P, Lutz WK, Schlatter C (1983) The relevance of covalent binding to mouse liver DNA to the carcinogenic action of hexachlorocyclohexane isomers. Carcinogenesis 4: 1267–1273
Schuppler J, Dammé J, Schulte-Hermann R (1983) Assay of some endogenous and synthetic sex steroids for tumor-initiating activity in rat liver using the Solt-Farber system. Carcinogenesis 4: 239–241
Tsibris JCM, McGuire P (1977) Microsomal activation of estrogens and binding to nucleic acids and proteins. Biochem Biophys Res Commun 78: 411–417
Viviani A, Lutz WK (1978) Modulation of the binding of the carcinogen benzo(a)pyrene to rat liver DNA in vivo by selective induction of microsomal and nuclear aryl hydrocarbon hydroxylase activity. Cancer Res 38: 4640–4644
Weisburger JH, Williams GM (1981) Carcinogen testing: Current problems and new approaches. Science 214: 401–407
Yager DJ and Yager R (1980) Oral contraceptive steroids as promotors of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40: 3680–3685
Yager DJ, Fifield DS (1982) Lack of hepatogenotoxicity of oral contraceptive steroids. Carcinogenesis 3: 625–628
Yaneva M, Dessev G (1976) Isolation and properties of structurated chromatin from Guerin Ascites tumor and rat liver. Eur J Biochem 66: 535–542
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caviezel, M., Lutz, W.K., Minini, U. et al. Interaction of estrone and estradiol with DNA and protein of liver and kidney in rat and hamster in vivo and in vitro. Arch Toxicol 55, 97–103 (1984). https://doi.org/10.1007/BF00346046
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00346046